Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates:: Correlation with results of NCCLS M27-A2 multicenter study

被引：11
|
作者：
Cantón, E
Pemán, J
Gobernado, M
Alvarez, E
Baquero, F
Cisterna, R
Gil, J
Martín-Mazuelos, E
Rubio, C
Sánchez-Sousa, A
Serrano, C
机构：
[1] Hosp Univ Fe, Ctr Invest, Univ Microbiol Expt, Valencia 46009, Spain
[2] Hosp Univ Fe, Microbiol Serv, Valencia 46009, Spain
[3] Hosp Univ Ramon & Cajal, Madrid, Spain
[4] Hosp Univ Basurto, Bilbao, Spain
[5] Univ Lozano Blesa, Hosp Clin, Zaragoza, Spain
[6] Hosp Univ Valme, Seville, Spain
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 04期
关键词：
D O I：
10.1128/AAC.49.4.1604-1607.2005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The ability of Sensititre YeastOne to discriminate isolates with reduced caspofungin susceptibility was determined against 36 Candida spp. (6 with a known FKS1 mutation). Results were compared with those of M27-A2. The MIC endpoint was 100% growth inhibition. Overall agreement (+/- 2 log(2)) was 87.16%. Sensititre YeastOne detected strains with reduced caspofungin susceptibility.
引用
收藏
页码：1604 / 1607
页数：4
相关论文
共 50 条
  • [31] Comparative evaluation of Sensititre YeastOne and VITEK 2 against the Clinical and Laboratory Standards Institute M27-E4 reference broth microdilution method for the antifungal susceptibility testing of Cryptococcus neoformans and Cryptococcus gattii
    Zhang, Min
    Zhou, Ziyi
    Wang, Dongjiang
    Zhou, Aiping
    Song, Guobin
    Chen, Xingchun
    Guo, Jian
    Wu, Wenjuan
    MEDICAL MYCOLOGY, 2022, 60 (03)
  • [32] Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins
    Siopi, Maria
    Pournaras, Spyros
    Meletiadis, Joseph
    JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (06) : 1714 - 1719
  • [33] International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole
    Espinel-Ingroff, A
    Barchiesi, F
    Cuenca-Estrella, M
    Pfaller, MA
    Rinaldi, M
    Rodriguez-Tudela, JL
    Verweij, PE
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) : 3884 - 3889
  • [34] Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against Aspergillus fumigatus and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values
    Melhem, Marcia S. C.
    Coelho, Vivian C.
    Fonseca, Claudia A.
    de Oliveira, Lidiane
    Bonfietti, Lucas X.
    Szeszs, Maria W.
    Magri, Marcello M. C.
    Dorneles, Francine S.
    Taguchi, Hideaki
    Moreira, Daniel V. S.
    Motta, Adriana L.
    Batista, Marjorie, V
    Kamei, Katsuhiko
    Shikanai-Yasuda, Maria A.
    PHARMACEUTICS, 2022, 14 (10)
  • [35] Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neofonnans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazolev
    Espinel-Ingroff, A.
    Canton, E.
    Gibbs, D.
    Wang, A.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (03) : 858 - 864
  • [36] Antifungal drug susceptibility testing of Candida sp by two methods:: CLSI(M27-A2) broth microdilution and the image analyser method Wider-I
    Rodriguez-Dominguez, M.
    Ayala, G.
    Fernandez-Olmos, A.
    Mercadillo, M.
    Alvarez, M.
    Sanchez-Sousa, A.
    Espinel-Ingroff, A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S565 - S565
  • [37] Comparison of the sensititre YeastOne® colorimetric antifungal panel with the modified clinical and laboratory standards institute broth microdilution (M38-A) method for antifungal susceptibility testing of dermatophytes
    Castro, C.
    Serrano, M. C.
    Valverde, A.
    Peman, J.
    Almeida, C.
    Martin-Mazuelos, E.
    CHEMOTHERAPY, 2008, 54 (06) : 427 - 430
  • [38] The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study
    Kim, Soo Hyun
    Shin, Jong Hee
    Kim, Eui-Chong
    Lee, Kyungwon
    Kim, Mi-Na
    Lee, Won Gil
    Uh, Young
    Lee, Hye Soo
    Lee, Mi-Kyung
    Jeong, Seok Hoon
    Jung, Sook In
    Park, Kyung Hwa
    Lee, Jin-Sol
    Shin, Myung Geun
    Suh, Soon Pal
    Ryang, Dong Wook
    MEDICAL MYCOLOGY, 2009, 47 (03) : 296 - 304
  • [39] Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values
    Pfaller, M. A.
    Chaturvedi, V.
    Diekema, D. J.
    Ghannoum, M. A.
    Holliday, N. M.
    Killian, S. B.
    Knapp, C. C.
    Messer, S. A.
    Miskou, A.
    Ramani, R.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2012, 73 (04) : 365 - 368
  • [40] Categorizing Susceptibility of Clinical Isolates of Candida auris to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion Method
    Nunnally, Natalie S.
    Damm, Tajah
    Lockhart, Shawn R.
    Berkow, Elizabeth L.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (04)
12345